Clinical

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action Lawsuit Against ProNAi Therapeutics, Inc. And a Lead Plaintiff Deadline of January 9, 2017 – DNAI

Related content 23 Nov – Safirstein Metcalf LLP Announces That A Class Action La.. 18 Nov – SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC N.. 14 Nov – DNAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong.. NEW YORK, Nov. 28, 2016 (GLOBE NEWSWIRE) — The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased shares of ProNAi …


What the Fitbit Lawsuit Means for Clinical researchers

Fitbit is facing a class-action lawsuit regarding the accuracy of their heart-rate data, which have been shown to be inaccurate by a margin of up to 20 beats per minute by researchers at California State Polytechnic University, Pomona. This news risks sending back to the drawing board many of us who have been optimistically experimenting with biotelemetry. We’ve been asked about the lawsuit nearly …


Fitbit’s Inaccurate Heart-Rate Tracking Can ‘put Consumers at Risk’

Fitbit is currently embroiled in a class-action lawsuit over the accuracy of its heart-rate tracking. As part of their case, the plaintiffs commissioned a scientific study of the accuracy of the Fitbit Charge HR and Surge. Wareable spoke to the scientist who was paid to do the testing, and unsurprisingly, he has bad things to say about Fitbit’s devices.


Lawyers Say Fitbit’s Heart Tracker Is Way Off

The heart rate tracker technology in fancier models of Fitbit starts to become inaccurate when people start exercising, according to a study included in an amended class-action lawsuit against the company. In a press release, plaintiffs’ lawyers say California State Polytechnic University put both Fitbits and ECG sensors on 43 separate subjects tested for 65 minutes of moderate to …